Marc Rubin

9.9k total citations · 4 hit papers
52 papers, 8.1k citations indexed

About

Marc Rubin is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Marc Rubin has authored 52 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 21 papers in Infectious Diseases and 15 papers in Oncology. Recurrent topics in Marc Rubin's work include Neutropenia and Cancer Infections (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (12 papers). Marc Rubin is often cited by papers focused on Neutropenia and Cancer Infections (14 papers), HIV/AIDS drug development and treatment (13 papers) and HIV Research and Treatment (12 papers). Marc Rubin collaborates with scholars based in United States, Malaysia and United Kingdom. Marc Rubin's co-authors include Christopher D. Stephen, Philip A. Pizzo, P A Pizzo, James W. Hathorn, Jules L. Dienstag, Eugene R. Schiff, Sharon L. Benoit, Thomas J. Walsh, Janet Gress and Emmanuel Roilides and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Marc Rubin

50 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ovarian Cancer

1993 2.7k citations Marc Rubin et al. profile →
A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection

1995 680 citations Jules L. Dienstag, Robert P. Perrillo et al. New England Journal of Medicine profile →
Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS

1996 595 citations Sharon L. Benoit, Marc Rubin et al. New England Journal of Medicine profile →
A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia

1986 478 citations Philip A. Pizzo, Janet Gress et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Rubin United States	33	2.6k	2.2k	2.1k	1.6k	1.4k	52	8.1k
Paul Deutsch United States	38	4.5k 1.7×	1.4k 0.6×	631 0.3×	4.5k 2.9×	264 0.2×	64	8.6k
Guido Antonelli Italy	47	2.3k 0.9×	2.5k 1.1×	1.0k 0.5×	1.0k 0.7×	64 0.0×	371	7.4k
Howard D. Strickler United States	53	506 0.2×	3.9k 1.8×	2.7k 1.3×	243 0.2×	260 0.2×	227	8.6k
Sarman Singh India	46	2.8k 1.1×	3.7k 1.7×	321 0.2×	201 0.1×	218 0.2×	335	7.9k
Mauro Moroni Italy	42	2.4k 0.9×	1.3k 0.6×	2.2k 1.1×	2.0k 1.3×	32 0.0×	165	6.7k
Michel Roger Canada	35	1.8k 0.7×	1.3k 0.6×	352 0.2×	1.9k 1.2×	244 0.2×	149	4.8k
Timothy M. Block United States	63	1.9k 0.7×	6.3k 2.8×	959 0.5×	922 0.6×	45 0.0×	232	12.6k
Robert Yarchoan United States	75	6.5k 2.5×	4.8k 2.2×	7.0k 3.3×	5.6k 3.6×	41 0.0×	334	18.7k
Naomi Aronson United States	40	950 0.4×	1.4k 0.6×	934 0.4×	350 0.2×	31 0.0×	164	6.0k
Mario A. Luna United States	71	1.9k 0.8×	2.9k 1.3×	6.5k 3.1×	64 0.0×	109 0.1×	274	14.4k

Countries citing papers authored by Marc Rubin

Since Specialization

Citations

This map shows the geographic impact of Marc Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rubin more than expected).

Fields of papers citing papers by Marc Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rubin. The network helps show where Marc Rubin may publish in the future.

Co-authorship network of co-authors of Marc Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Rubin. A scholar is included among the top collaborators of Marc Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Rubin. Marc Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Shumin, et al.. (2017). Emerging technologies for home‐based semen analysis. Andrology. 6(1). 10–19. 60 indexed citations

Chen, Chaoping, Jing Jin, Marc Rubin, et al.. (2007). Association of Gag Multimers with Filamentous Actin During Equine Infectious Anemia Virus Assembly. Current HIV Research. 5(3). 315–323. 19 indexed citations

Kuritzkes, Daniel R., David Shugarts, Judy Johnson, et al.. (2000). Emergence of Dual Resistance to Zidovudine and Lamivudine in HIV-1–Infected Patients Treated With Zidovudine Plus Lamivudine as Initial Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 23(1). 26–34. 36 indexed citations

Dienstag, Jules L., Eugene R. Schiff, Mack C. Mitchell, et al.. (1999). Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy. Hepatology. 30(4). 1082–1087. 153 indexed citations

Hunt, Christine M., Nathaniel Brown, & Marc Rubin. (1999). Lamivudine Therapy of Chronic Hepatitis B. Advances in experimental medicine and biology. 458. 11–21. 5 indexed citations

Lewis, Linda, David Venzon, Jarrod E. Church, et al.. (1996). Lamivudine in Children with Human Immunodeficiency Virus Infection: A Phase I/II Study. The Journal of Infectious Diseases. 174(1). 16–25. 67 indexed citations

Kuritzkes, Daniel R., Joseph Quinn, Sharon L. Benoit, et al.. (1996). Drug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. AIDS. 10(9). 975–981. 153 indexed citations

Dienstag, Jules L., et al.. (1995). A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection. New England Journal of Medicine. 333(25). 1657–1661. 680 indexed citations breakdown →

Pluda, James M., Timothy P. Cooley, Julio Montaner, et al.. (1995). A Phase I/II Study of 2'-Deoxy-3'-Thiacytidine (Lamivudine) in Patients with Advanced Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 171(6). 1438–1447. 87 indexed citations

10.

Mueller, Brigitta U., Jane Skelton, Diana P. Callender, et al.. (1992). A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients.. Journal of Clinical Oncology. 10(12). 1943–1948. 148 indexed citations

11.

Roilides, Emmanuel, T. J. Walsh, P A Pizzo, & Marc Rubin. (1991). Granulocyte Colony-Stimulating Factor Enhances the Phagocytic and Bactericidal Activity of Normal and Defective Human Neutrophils. The Journal of Infectious Diseases. 163(3). 579–583. 267 indexed citations

12.

Walsh, Thomas J., James Lee, Julius Lecciones, et al.. (1991). Empiric Therapy with Amphotericin B in Febrile Granulocytopenic Patients. Clinical Infectious Diseases. 13(3). 496–503. 79 indexed citations

13.

Pizzo, P. A., Marc Rubin, Alison G. Freifeld, & Thomas J. Walsh. (1991). The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. The Journal of Pediatrics. 119(5). 679–694. 101 indexed citations

14.

Pizzo, Philip A., Marc Rubin, Alison G. Freifeld, & Thomas J. Walsh. (1991). The child with cancer and infection. II. Nonbacterial infections. The Journal of Pediatrics. 119(6). 845–857. 56 indexed citations

15.

Roilides, Emmanuel, Susan D. Mertins, Janie Eddy, et al.. (1990). Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. The Journal of Pediatrics. 117(4). 531–540. 98 indexed citations

16.

Rubin, Marc, Thomas J. Walsh, Karina Butler, et al.. (1990). The Febrile Neutropenic Patient: Newer Options for Empirical Therapy. Hämatologie und Bluttransfusion. 33. 531–538. 1 indexed citations

17.

Walsh, Thomas J., Shizuko Aoki, Françoise Méchinaud, et al.. (1990). Effects of Preventive, Early, and Late Antifungal Chemotherapy with Fluconazole in Different Granulocytopenic Models of Experimental Disseminated Candidiasis. The Journal of Infectious Diseases. 161(4). 755–760. 52 indexed citations

18.

Walsh, Thomas J., James Lee, Shizuko Aoki, et al.. (1990). Experimental Basis for Use of Fluconazole for Preventive or Early Treatment of Disseminated Candidiasis in Granulocytopenic Hosts. Clinical Infectious Diseases. 12(Supplement_3). S307–S317. 41 indexed citations

19.

Adamson, Peter C., et al.. (1989). Pertussis in a previously immunized child with human immunodeficiency virus infection. The Journal of Pediatrics. 115(4). 589–592. 22 indexed citations

20.

Pizzo, Philip A., Janie Eddy, Frank M. Balis, et al.. (1988). Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV Infection. New England Journal of Medicine. 319(14). 889–896. 343 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact